NCT06395246Not yet recruiting

Circulating Microvesicles Regulating Metabolic Homeostasis in Obesity After Caloric Restriction Programs

Name: Clinical Trial NCT06395246
Creator: Institut Investigacio Sanitaria Pere Virgili
Keywords: Obesity, Active Comparator: Continuous calorie restriction, behavioral, clinical trial

The Usefulness of Circulating Microvesicles (Host and Bacterial) in Regulating Metabolic Homeostasis in Obesity Randomized Study of Parallel Arms in Obese Patients Undergoing Caloric Restriction Diet vs. Early Time-restricted Eating

Institut Investigacio Sanitaria Pere VirgiliClinicalTrials.govbehavioral

Verified

Study focus

Disease/Condition: Obesity
Drug/Device/Intervention: Active Comparator: Continuous calorie restriction
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Institut Investigacio Sanitaria Pere Virgili

Timeline & enrollment

Phase: N/A
Start date: May 20, 2024
End date: Dec 20, 2024
Enrollment: 60 participants

Primary outcome

Anthropometric measurements (I),Anthropometric measurements (II),Anthropometric measurements (III),Anthropometric measurements (IV),Anthropometric measurements (V),Body composition (I),Body composition (II),Body composition (III),Brown fat

Summary

The main aim of the present study is to evaluate the effectiveness of two dietary protocols: Daily Caloric Restriction (DCR) and Early Time-Restricted Feeding + DCR (eTRE) on metabolic homeostasis and the influence of circulating extracellular vesicles (EVs) as inter-organ communication elements in obese patients.

ICD-10 classifications

ObesityOther obesityObesity, unspecifiedObesity due to excess caloriesObesity and other hyperalimentation

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06395246
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06395246 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut Investigacio Sanitaria Pere Virgili and is currently Not yet recruiting. The study focuses on Obesity. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.